Ronald Lautner
Moelndal, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Effects of APOE ε4 on neuroimaging, cerebrospinal fluid biomarkers, and cognition in prodromal Alzheimer's disease.
Journal: Neurobiology of aging
Published: February 07, 2018
Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations.
Journal: Alzheimer's research & therapy
Published: June 12, 2017
Apolipoprotein E genotypes and longevity across dementia disorders.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: December 16, 2016
Blood biomarkers indicate mild neuroaxonal injury and increased amyloid β production after transient hypoxia during breath-hold diving.
Journal: Brain injury
Published: July 09, 2016
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
Journal: The Lancet. Neurology
Published: September 13, 2015
CSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4.
Journal: Molecular psychiatry
Published: February 20, 2013
Plasma amyloid-β in patients with Tangier disease.
Journal: Journal of Alzheimer's disease : JAD
Published: February 08, 2013
Cerebrospinal fluid analyses for the diagnosis of subarachnoid haemorrhage and experience from a Swedish study. What method is preferable when diagnosing a subarachnoid haemorrhage?
Journal: Clinical chemistry and laboratory medicine
Published: November 17, 2012
Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementia.
Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementia.
Journal: Journal of Alzheimer's disease : JAD
Published: August 15, 2012
Last Updated: 09/26/2026